Navigation Links
Simultaneous Applications Submitted to FDA and EMA for Siltuximab for the Treatment of Multicentric Castleman Disease, a Rare Blood Disorder
Date:9/3/2013

RARITAN, N.J., Sept. 3, 2013 /PRNewswire/ -- Janssen Research & Development, LLC ("Janssen") announced the simultaneous submissions of a Biologic License Application (BLA) to the United States Food and Drug Administration (U.S. FDA) and a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for siltuximab for the treatment of patients with multicentric Castleman disease (MCD) who are HIV-negative and human herpes virus-8 (HHV-8)-negative.

MCD is a rare disorder in which lymphocytes, a certain type of white blood cells, are over-produced and lead to enlargement of lymph nodes.1, 2 This can cause a variety of symptoms and weaken the immune system, making it hard to fight infection. Infections in people with MCD can be very serious and may even be fatal.3 Currently, there are no approved treatments in the U.S. or European Union (EU) for this rare blood disorder.

"We're proud of our work on siltuximab. As a rare disease with a small patient population, MCD is an area of significant unmet need," said Peter F. Lebowitz, M.D., Ph.D., global oncology therapeutic area head, Janssen. "Siltuximab works by targeting interleukin-6 which appears to be the critical driver of this disease. By focusing on core biologic mechanisms, we now have the potential of helping patients with a condition that is challenging to treat."  

Siltuximab has been granted orphan drug status in MCD in the U.S. and EU. The siltuximab regulatory submissions include data from a randomized, multi-national, double-blind, placebo-controlled study (MCD2001) and data from two non-randomized supportive studies. The MCD2001 study assessed the efficacy and safety of siltuximab plus best supportive care (BSC) compared with placebo plus BSC in patients with MCD.4 In the study, 79 patients were randomly assigned in a 2:1 ratio to one of the two treatment
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. First Large-Scale Population-Based Study in the U.S. Shows Hologics 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
2. Philips IMR offers new capabilities to simultaneously reduce CT Radiation and enhance image quality
3. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
4. Rubicon Genomics Launches ThruPLEX™ Family of Sample Preparation Products for Next Generation Sequencing Applications
5. Philips demonstrates innovations in nuclear medicine imaging with a comprehensive portfolio of NM applications for IntelliSpace Portal
6. Clinical Safety Data for ChromaDex®s Patented pTeroPure® (pterostilbene) Released at 6th World Congress on Polyphenols Applications in Paris
7. UltraTape announces Cleanroom Labels for Cryogenic Laboratory applications
8. New, Affordable Flow Cytometer Cell Sorter Expands Access to Wider Range of Life Science Applications
9. New Wireless Keyboard Rechargeable, Washable for Healthcare Applications
10. Frost & Sullivan: Label-Free Technology is a High Potential Market with Myriad Unexplored Applications
11. Radiotherapy Devices Market By Technology, Applications & Products (2011 - 2016)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015  Bayer HealthCare today announced that the ... the company,s Biologics License Application (BLA) for BAY ... seeking FDA approval of the investigational compound, proposed ... A in children and adults. ... to hemophilia A patients who need them," said ...
(Date:3/4/2015)...   HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... Godshall is scheduled to present at the 2015 ... on Tuesday, March 10, 2015.  The conference is being ... in Florida . A ...
(Date:3/4/2015)... INDIANAPOLIS , March 4, 2015  Students from ... look at how new medicines are discovered. Through a ... and fourth-year medical students from IU School of Medicine ... physicians working at Lilly play different and important roles ... "As a former medical educator, scientific investigator, and ...
Breaking Medicine Technology:FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3HeartWare Presentation At The 2015 Barclays Global Healthcare Conference To Be Webcast 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 3
(Date:3/5/2015)... The pleasing melodies of live bluegrass music will greet ... and hand cycle ride as they arrive in Frederick, Maryland ... Band will present a free concert for riders who ... in Arlington, Virginia. , “We are thrilled and honored to ... sacrificed so much. We love being to give back a ...
(Date:3/5/2015)... TULSA, OK (PRWEB) March 05, 2015 ... been to build a faster, safer, smarter commercial lifting ... the company has an increasing role in more ... lifting systems last month – Octapad System for lifting ... place concrete barriers during road construction projects. , ...
(Date:3/5/2015)... Salt Lake City,Utah (PRWEB) March 05, 2015 ... that manufactures microFET medical dynamometers, ergoFET physical ... acquisition systems with sensors for ergonomics, engineering, ... new microFET Digital Handgrip Dynamometer, available at ... Handgrip was designed to offer healthcare professionals ...
(Date:3/5/2015)... The Shaolin Chan Foundation featured Grand ... at Atlanta Shaolin Institute along with Grandmaster Shi DeRu ... Suite 500A, city of Peachtree Corners, Georgia. The event ... a non-profit organization that promotes natural, healthy living and ... , The seminar was well received by over 50 ...
(Date:3/4/2015)... Nevada (PRWEB) March 04, 2015 MyCpapStore.com, ... pleased to announce that they sell quality products designed ... Vegas, Nevada, this company obtains its merchandise from name-brand ... known history of good performance. , Sleep apnea is ... is typically caused by reduced or restricted airflow. The ...
Breaking Medicine News(10 mins):Health News:Flower Hill String Band to Welcome Face of America with Bluegrass Music 2Health News:Flower Hill String Band to Welcome Face of America with Bluegrass Music 3Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 2Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 3Health News:New Handgrip Strength Tester Receives Rave Reviews At Physical Therapy Conference 2Health News:Top Martial Arts Master Wu Bin of China, Has Successfully Conducted a Time-Honored Kung Fu Seminar for Health & Wellness at Shaolin Institute, Atlanta, GA 2Health News:Top Martial Arts Master Wu Bin of China, Has Successfully Conducted a Time-Honored Kung Fu Seminar for Health & Wellness at Shaolin Institute, Atlanta, GA 3Health News:Sleep Apnea Machines CPAP and BiPap Machines Now Available for Sale 2
... many people, but few have the chance to meet ... the disease. , This month two world renowned cancer ... to explain how their research is contributing to a ... , The Hunter Medical Research Institute (HMRI) Public Lecture, ...
... A research team at the Ludwig Institute and Uppsala University ... factor that is of crucial importance for the survival and ... issue of Nature Cell Biology, opens up an ... among other types. , Our cells ability to understand signals ...
... -- A new study conducted at a large university ... symptoms of tanning dependence, including symptoms similar to alcohol ... those with a tanning dependence tend to be more ... The study by researchers at Fox Chase Cancer ...
... One in three people with a high risk of developing cardiovascular ... according to a major UK study in the September issue of ... , The shortfall in identifying people at high risk is greatest ... than 71,000 men and women, which was carried out by Oxford ...
... to the 2003 guidelines, important new recommendations have been formulated ... networks of hospitals with different levels of technology using the ... , the selection of primary PCI vs fibrinolytic therapy ... PCI and fibrinolytis , secondary prevention , ...
... even for a few short hours during the night, can ... organs. A new article in the September 15th issue of ... team, reports that losing sleep for even part of one ... inflammation. The findings suggest a good night,s sleep can ...
Cached Medicine News:Health News:Experts to share how research is tackling cancer 2Health News:New discovery about growth factor can be breakthrough for cancer research 2Health News:Survey: 'Tanorexia' common among university students 2Health News:Millions face undiagnosed heart risk say researchers after mass screening 2Health News:Millions face undiagnosed heart risk say researchers after mass screening 3Health News:Loss of sleep, even for a single night, increases inflammation in the body 2
Round knurled handle. Overall length 130 mm....
Optimum C/D/S Solution is a sterile cleaning, disinfecting, and storage solution for use with fluorosilicone acrylate and silicone acrylate rigid gas permeable (RGP) and hard contact lenses....
5 inch (12.7 cm), 2 x 5 mm blade....
Nicati foreign body spud....
Medicine Products: